Literature DB >> 30877459

Diagnostic accuracy of hepatic proton density fat fraction measured by magnetic resonance imaging for the evaluation of liver steatosis with histology as reference standard: a meta-analysis.

Yali Qu1, Mou Li1, Gavin Hamilton2, Yingzhen N Zhang2, Bin Song3.   

Abstract

OBJECTIVES: The aim of this meta-analysis was to evaluate the diagnostic accuracy of hepatic magnetic resonance imaging-proton density fat fraction (MRI-PDFF) for the assessment of liver steatosis (LS) with histology as reference standard.
METHODS: A systematic literature search was performed to identify pertinent studies. Quality analyses were conducted by Quality Assessment of Diagnostic Accuracy Studies-2. Diagnostic data were extracted and inconsistency index was calculated for LS≥G1, LS≥G2, and LS=G3, respectively. The area under summary receiver operating characteristic curve (AUC) served as the indicator of diagnostic accuracy. The pooled sensitivity and specificity were calculated if threshold effect was absent.
RESULTS: Thirteen studies containing 1100 subjects were included. There was significant threshold effect for LS≥G1. The AUCs for LS≥G1, LS≥G2, and LS=G3 were 0.98 (95% confidence interval (CI) 0.76, 1.00), 0.91 (95% CI 0.89, 0.94), and 0.92 (95% CI 0.89, 0.94), respectively. The pooled sensitivities for LS≥G2 and LS=G3 were 0.83 (95% CI 0.75, 0.88) and 0.79 (95% CI 0.63, 0.90), respectively; the pooled specificities for LS≥G2 and LS=G3 were 0.89 (95% CI 0.84, 0.92) and 0.89 (95% CI 0.84, 0.92), respectively.
CONCLUSIONS: MRI-PDFF has high diagnostic accuracy at detecting and grading LS with histology as reference standard, suggesting that MRI-PDFF is able to provide an accurate quantification of LS in clinical trials and patient care. KEY POINT: • MRI-PDFF is able to provide an accurate quantification of LS in clinical trials and patient care.

Entities:  

Keywords:  Area under curve; Fatty liver; Magnetic resonance imaging; Meta-analysis

Mesh:

Year:  2019        PMID: 30877459     DOI: 10.1007/s00330-019-06071-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  58 in total

Review 1.  Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews.

Authors:  Johannes B Reitsma; Afina S Glas; Anne W S Rutjes; Rob J P M Scholten; Patrick M Bossuyt; Aeilko H Zwinderman
Journal:  J Clin Epidemiol       Date:  2005-10       Impact factor: 6.437

2.  A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.

Authors:  Jeremy S Paige; Gregory S Bernstein; Elhamy Heba; Eduardo A C Costa; Marilia Fereirra; Tanya Wolfson; Anthony C Gamst; Mark A Valasek; Grace Y Lin; Aiguo Han; John W Erdman; William D O'Brien; Michael P Andre; Rohit Loomba; Claude B Sirlin
Journal:  AJR Am J Roentgenol       Date:  2017-03-07       Impact factor: 3.959

Review 3.  Recommendations for liver biopsy evaluation in non-alcoholic fatty liver disease.

Authors:  L M Stinton; R Loomba
Journal:  Minerva Gastroenterol Dietol       Date:  2014-03

4.  Quantitative MRI for hepatic fat fraction and T2* measurement in pediatric patients with non-alcoholic fatty liver disease.

Authors:  Jie Deng; Mark H Fishbein; Cynthia K Rigsby; Gang Zhang; Samantha E Schoeneman; James S Donaldson
Journal:  Pediatr Radiol       Date:  2014-05-20

5.  A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.

Authors:  Ilkay S Idilman; Onur Keskin; Azim Celik; Berna Savas; Atilla Halil Elhan; Ramazan Idilman; Musturay Karcaaltincaba
Journal:  Acta Radiol       Date:  2015-04-08       Impact factor: 1.990

6.  Percutaneous liver biopsy: patients' point of view.

Authors:  Luis Fernández-Salazar; Benito Velayos; Rocío Aller; Félix Lozano; José A Garrote; José M González
Journal:  Scand J Gastroenterol       Date:  2011-03-02       Impact factor: 2.423

7.  Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Michael S Middleton; Cynthia Behling; Kimberly P Newton; Hannah I Awai; Melissa N Paiz; Jessica Lam; Jonathan C Hooker; Gavin Hamilton; John Fontanesi; Claude B Sirlin
Journal:  Hepatology       Date:  2015-02-05       Impact factor: 17.425

Review 8.  Nonalcoholic fatty liver disease: a systematic review.

Authors:  Mary E Rinella
Journal:  JAMA       Date:  2015-06-09       Impact factor: 56.272

9.  Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.

Authors:  An Tang; Justin Tan; Mark Sun; Gavin Hamilton; Mark Bydder; Tanya Wolfson; Anthony C Gamst; Michael Middleton; Elizabeth M Brunt; Rohit Loomba; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2013-02-04       Impact factor: 11.105

10.  Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.

Authors:  Saumya Jayakumar; Michael S Middleton; Eric J Lawitz; Parvez S Mantry; Stephen H Caldwell; Hays Arnold; Anna Mae Diehl; Reem Ghalib; Magdy Elkhashab; Manal F Abdelmalek; Kris V Kowdley; C Stephen Djedjos; Ren Xu; Ling Han; G Mani Subramanian; Robert P Myers; Zachary D Goodman; Nezam H Afdhal; Michael R Charlton; Claude B Sirlin; Rohit Loomba
Journal:  J Hepatol       Date:  2018-10-04       Impact factor: 25.083

View more
  9 in total

Review 1.  Imaging Modalities in Pediatric NAFLD.

Authors:  Suraj D Serai; Jennifer Panganiban; Manish Dhyani; Andrew J Degnan; Sudha A Anupindi
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-04-13

2.  The relationship between liver triglyceride composition and proton density fat fraction as assessed by 1 H MRS.

Authors:  Gavin Hamilton; Alex N Schlein; Tanya Wolfson; Guilherme M Cunha; Kathryn J Fowler; Michael S Middleton; Rohit Loomba; Claude B Sirlin
Journal:  NMR Biomed       Date:  2020-03-03       Impact factor: 4.044

3.  Quantitative Ultrasound Assessment of Hepatic Steatosis.

Authors:  Artem Kaliaev; Wilson Chavez; Jorge Soto; Fahimul Huda; Hua Xie; Man Nguyen; Vijay Shamdasani; Stephan Anderson
Journal:  J Clin Exp Hepatol       Date:  2022-01-31

Review 4.  European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint European Society for Clinical Nutrition and Metabolism / United European Gastroenterology guideline.

Authors:  Stephan C Bischoff; Rocco Barazzoni; Luca Busetto; Marjo Campmans-Kuijpers; Vincenzo Cardinale; Irit Chermesh; Ahad Eshraghian; Haluk Tarik Kani; Wafaa Khannoussi; Laurence Lacaze; Miguel Léon-Sanz; Juan M Mendive; Michael W Müller; Johann Ockenga; Frank Tacke; Anders Thorell; Darija Vranesic Bender; Arved Weimann; Cristina Cuerda
Journal:  United European Gastroenterol J       Date:  2022-08-12       Impact factor: 6.866

Review 5.  Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD.

Authors:  Nobuharu Tamaki; Veeral Ajmera; Rohit Loomba
Journal:  Nat Rev Endocrinol       Date:  2021-11-23       Impact factor: 47.564

6.  How to select the quantitative magnetic resonance technique for subjects with fatty liver: A systematic review.

Authors:  You-Wei Li; Yang Jiao; Na Chen; Qiang Gao; Yu-Kun Chen; Yuan-Fang Zhang; Qi-Ping Wen; Zong-Ming Zhang
Journal:  World J Clin Cases       Date:  2022-09-06       Impact factor: 1.534

7.  Hepatic fat quantification of magnetic resonance imaging whole-liver segmentation for assessing the severity of nonalcoholic fatty liver disease: comparison with a region of interest sampling method.

Authors:  Qin-He Zhang; Ying Zhao; Shi-Feng Tian; Lu-Han Xie; Li-Hua Chen; An-Liang Chen; Nan Wang; Qing-Wei Song; Hao-Nan Zhang; Li-Zhi Xie; Zhi-Wei Shen; Ai-Lian Liu
Journal:  Quant Imaging Med Surg       Date:  2021-07

8.  Association of hepatic steatosis derived from ultrasound and quantitative MRI with prediabetes in the general population.

Authors:  Till Ittermann; Henry Völzke; Muhammad Naeem; Robin Bülow; Sabine Schipf; Nicole Werner; Marcus Dörr; Markus M Lerch; Jens-Peter Kühn; Wolfgang Rathmann; Matthias Nauck; Marcello Ricardo Paulista Markus
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

9.  PNPLA3 Single Nucleotide Polymorphism Prevalence and Association with Liver Disease in a Diverse Cohort of Persons Living with HIV.

Authors:  Kenneth E Sherman; Susan D Rouster; Heidi Meeds; Javier Tamargo; Jun Chen; Richard Ehman; Marianna Baum
Journal:  Biology (Basel)       Date:  2021-03-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.